Ticagrelor With and Without Aspirin in Patients With Diabetes Mellitus

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 105 participants.

Also called NCT04484259

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 105 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04484259
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04484259. Randomized; no masking; primary purpose treatment. Start 2021-03-31 (actual); primary completion 2024-01-29 (actual). Results posted on 2025-03-30.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ticagrelor With and Without Aspirin in Patients With Diabetes Mellitus
Acronym
OPTIMUS-7
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
Ticagrelor monotherapy
Intervention (Drug)
Ticagrelor plus aspirin
Intervention (Drug)
Clopidogrel with aspirin
Lead sponsor
University of Florida (class: other)
Collaborator
AstraZeneca (class: industry)

Record details

Record id
cardio:ct-nct04484259
Content hash
d1bb6d27d6aaad8789c738b55a12b738e0733eb992fc96a474e7e8c82ecc5d67